» Articles » PMID: 32268899

Novel PYGL Mutations in Chinese Children Leading to Glycogen Storage Disease Type VI: Two Case Reports

Overview
Journal BMC Med Genet
Publisher Biomed Central
Specialty Genetics
Date 2020 Apr 10
PMID 32268899
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: PYGL mutations can cause liver phosphorylase deficiency, resulting in a glycogenolysis disorder, namely, glycogen storage disease (GSD) VI. The disease is rarely reported in the Chinese population. GSD VI is mainly characterized in untreated children by hepatomegaly, growth retardation and elevated liver transaminases.

Case Presentation: In this study, we report two GSD VI patients with growth retardation and abnormal liver function. There was no obvious hepatomegaly for one of them. Whole exome sequencing (WES) combined with copy number variation analysis was performed. We found a novel homozygous gross deletion, c.1621-258_2178-23del, including exons 14-17 of PYGL in patient 1. The exons 14-17 deletion of PYGL resulted in an in-frame deletion of 186 amino acids. Compound heterozygous mutations of PYGL were identified in patient 2, including a novel missense mutation c.1832C > T/p.A611V and a recurrent nonsense mutation c.280C > T/p.R94X. After treatment with uncooked cornstarch (UCS) 8 months for patient 1 and 13 months for patient 2, the liver transaminases of both patients decreased to a normal range and their stature was improved. However, patient 1 still showed mild hypertriglyceridemia.

Conclusions: We describe two GSD VI patients and expand the spectrum of PYGL mutations. Patient 1 in this study is the first GSD VI case that showed increased transaminases without obvious hepatomegaly due to a novel homozygous gross deletion of PYGL identified through WES.

Citing Articles

Cellular hierarchy framework based on single-cell/multi-patient sample sequencing reveals metabolic biomarker PYGL as a therapeutic target for HNSCC.

Guan J, Xu X, Qiu G, He C, Lu X, Wang K J Exp Clin Cancer Res. 2023; 42(1):162.

PMID: 37420300 PMC: 10329320. DOI: 10.1186/s13046-023-02734-w.


Identification of glycogen phosphorylase L as a potential target for lung cancer.

He X, Lyu W, Li X, Zhao H, Qi L, Lu J Med Oncol. 2023; 40(7):211.

PMID: 37347364 DOI: 10.1007/s12032-023-02069-8.


Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases.

Dong R, Wei X, Zhang K, Song F, Lv Y, Gao M Front Genet. 2022; 13:932760.

PMID: 36105079 PMC: 9465291. DOI: 10.3389/fgene.2022.932760.


Integrated liver proteomics and metabolomics identify metabolic pathways affected by pantothenic acid deficiency in Pekin ducks.

Tang J, Wu Y, Zhang B, Liang S, Guo Z, Hu J Anim Nutr. 2022; 11:1-14.

PMID: 35950191 PMC: 9356036. DOI: 10.1016/j.aninu.2022.03.008.


miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.

Wang G, Tao X, Peng L Bioengineered. 2022; 13(5):12985-12997.

PMID: 35611851 PMC: 9275946. DOI: 10.1080/21655979.2022.2079304.


References
1.
Burwinkel B, Bakker H, Herschkovitz E, Moses S, Shin Y, Kilimann M . Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998; 62(4):785-91. PMC: 1377030. DOI: 10.1086/301790. View

2.
Beauchamp N, Taybert J, Champion M, Layet V, Heinz-Erian P, Dalton A . High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis. 2007; 30(5):722-34. DOI: 10.1007/s10545-007-0499-9. View

3.
Chang S, Rosenberg M, Morton H, Francomano C, Biesecker L . Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998; 7(5):865-70. DOI: 10.1093/hmg/7.5.865. View

4.
Wilson L, Cho J, Estrella A, Smyth J, Wu R, Chengsupanimit T . Liver Glycogen Phosphorylase Deficiency Leads to Profibrogenic Phenotype in a Murine Model of Glycogen Storage Disease Type VI. Hepatol Commun. 2019; 3(11):1544-1555. PMC: 6824077. DOI: 10.1002/hep4.1426. View

5.
Wang J, Cui H, Lee N, Hwu W, Chien Y, Craigen W . Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med. 2012; 15(2):106-14. DOI: 10.1038/gim.2012.104. View